Close

Viking Therapeutics (VKTX) Tops Q4 EPS by 2c

March 21, 2017 4:06 PM EDT

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings